Short Supply Limits Access to Newly Authorized COVID-19 Oral Pills

Though the FDA last week authorized the first COVID-19 oral antivirals for at-home use — Pfizer’s Paxlovid and Merck’s and Ridgeback Biotherapeutics’ molnupiravir — access to the pills will be limited in the new year.
Source: Drug Industry Daily